IL68970A0 - Antiarteriosclerotic compositions containing 1,4-dihydropyridines and their preparation - Google Patents

Antiarteriosclerotic compositions containing 1,4-dihydropyridines and their preparation

Info

Publication number
IL68970A0
IL68970A0 IL68970A IL6897083A IL68970A0 IL 68970 A0 IL68970 A0 IL 68970A0 IL 68970 A IL68970 A IL 68970A IL 6897083 A IL6897083 A IL 6897083A IL 68970 A0 IL68970 A0 IL 68970A0
Authority
IL
Israel
Prior art keywords
antiarteriosclerotic
dihydropyridines
preparation
compositions containing
compositions
Prior art date
Application number
IL68970A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL68970A0 publication Critical patent/IL68970A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL68970A 1982-06-15 1983-06-13 Antiarteriosclerotic compositions containing 1,4-dihydropyridines and their preparation IL68970A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823222367 DE3222367A1 (de) 1982-06-15 1982-06-15 Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung

Publications (1)

Publication Number Publication Date
IL68970A0 true IL68970A0 (en) 1983-10-31

Family

ID=6166052

Family Applications (1)

Application Number Title Priority Date Filing Date
IL68970A IL68970A0 (en) 1982-06-15 1983-06-13 Antiarteriosclerotic compositions containing 1,4-dihydropyridines and their preparation

Country Status (9)

Country Link
JP (1) JPS595114A (xx)
BE (1) BE897035A (xx)
CA (1) CA1228549A (xx)
DE (1) DE3222367A1 (xx)
ES (1) ES523244A0 (xx)
FR (1) FR2528425B1 (xx)
IL (1) IL68970A0 (xx)
IT (1) IT1175920B (xx)
ZA (1) ZA834344B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition
GB2180532B (en) * 1985-09-17 1989-08-23 Inst Organicheskogo Sinteza Ak Alkoxy-and phenoxy-alkyl-esters of 2,6-dimethyl-4-(2-difluoromethoxyphenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid
DE4222770A1 (de) * 1992-07-10 1994-01-13 Bayer Ag Lichtaktivierbare 1-(2-Nitrobenzyl)-substituierte 1,4-Dihydropyridine
DE4328884A1 (de) * 1993-08-27 1995-03-02 Bayer Ag Verwendung von N-alkylierten 1,4-Dihydropyridincarbonsäureestern als Arzneimittel
AU2002361992A1 (en) * 2001-12-20 2003-07-09 Bayer Aktiengesellschaft 1,4-dihydro-1,4-diphenylpyridine derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
DE2335466A1 (de) * 1973-07-12 1975-01-30 Bayer Ag Alkoxyalkyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2549568C3 (de) * 1975-11-05 1981-10-29 Bayer Ag, 5090 Leverkusen 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE3222367A1 (de) 1983-12-15
IT8321465A0 (it) 1983-06-03
FR2528425A1 (fr) 1983-12-16
JPS595114A (ja) 1984-01-12
CA1228549A (en) 1987-10-27
IT1175920B (it) 1987-08-12
BE897035A (fr) 1983-12-13
JPH0553774B2 (xx) 1993-08-10
DE3222367C2 (xx) 1992-02-13
ZA834344B (en) 1984-03-28
ES8403456A1 (es) 1984-03-16
ES523244A0 (es) 1984-03-16
FR2528425B1 (fr) 1987-02-06

Similar Documents

Publication Publication Date Title
DE3369517D1 (en) Didehydromilbemycin derivatives, their preparation and compositions containing them
IL58123A0 (en) 4,5-diaryl-2-nitroimidazoles their preparation and pharmaceutical compositions containing them
IL73706A0 (en) 2,2'-iminobisethanol derivatives,their preparation and pharmaceutical compositions containing them
GB2103203B (en) 1,4-dihydropyridines, their preparation and pharmaceutical compositions containing them
IL73332A (en) 5-amino-6-phenyl-2,3-dihydro-3-imino-1,2,4-triazine derivatives,their preparation and pharmaceutical compositions containing them
IL71187A0 (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions containing them
IL61930A (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it
IL63368A0 (en) 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines,their preparation and pharmaceutical compositions containing them
ZA832927B (en) Benzoazacycloalkyl-spiro-imidazolidines,their preparation and compositions containing them
IL72488A (en) N-sulfonyl-n'-phosphono-methylglycinamide derivatives,their preparation and herbicidal compositions containing them
ZW16583A1 (en) Milbemycind derivatives their preparation and compositions containing them
IL75943A0 (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL69796A (en) Phenylcycloalkylalkane derivatives,their preparation and arthropodicidal compositions containing them
IL68970A0 (en) Antiarteriosclerotic compositions containing 1,4-dihydropyridines and their preparation
IL64563A0 (en) 3,4-bis-substituted 1,2,5-oxidiazole 2-oxides,their preparation and pharmaceutical compositions containing them
IL76823A0 (en) 1,2,4-triazolo-carbamates,their preparation and pharmaceutical compositions containing them
IL72152A0 (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL64252A (en) 3,3-dimethyl-indolin-2-ones,their preparation and pharmaceutical compositions containing them
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
IL73278A0 (en) Pharmaceutical compositions containing 1,2-dithiolan derivatives,certain such derivatives and their preparation
IL72749A0 (en) 16-fluoro-16,17-didehydro prostanoids,their preparation and pharmaceutical compositions containing them
IL75485A0 (en) Ethanolamine compounds,their preparation and pharmaceutical compositions containing them
EP0127371A3 (en) 1,n-diaryl-4,5-dihydro-1h-pyrazol-3-amines, compositions containing them and methods for their preparation
IL68831A (en) 2,2-dimethyl-3-aryl-cyclo-butanones and their preparation
GB2067560B (en) 1-phenyl-4-morpholino-1-buten-3-ol derivatives their preparation and compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
KB20 Patent renewed for 20 years
EXP Patent expired